DepoDirect
DepoDirect helps busy legal teams schedule and manage remote depositions with automation, flat-rate pricing, and instant transcripts.
Enter
Enter is a Brazilian AI platform that runs high-volume litigation for corporate legal departments.
DepoDirect vs Enter
At a Glance
| Detail | DepoDirect | Enter |
|---|---|---|
| Category | eDiscovery | eDiscovery |
| Total raised | Not disclosed | $135M |
| Rounds tracked | Not disclosed | 2 |
| Latest round | Not disclosed | Series B, $100M · May 2026 |
| Last valuation | Not disclosed | $1.2B |
| Lead investors | Not disclosed | Founders Fund, Sequoia Capital |
| Built for | Not disclosed | In-house teams |
| Headquarters | Not disclosed | Brazil |
Funding, Side by Side
DepoDirect rounds
No public rounds tracked yet.
Enter rounds
- May 2026Series B$100M
- Sep 2025Series A$35M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, DepoDirect or Enter?
- Enter has raised $135M in disclosed funding, compared with no disclosed amount for DepoDirect.
- What is DepoDirect best for?
- DepoDirect helps busy legal teams schedule and manage remote depositions with automation, flat-rate pricing, and instant transcripts.
- What is Enter best for?
- Enter is a Brazilian AI platform that runs high-volume litigation for corporate legal departments.
Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.